Synlogic, Inc. (SYBX) Stock Price & Analysis
Synlogic, Inc. (SYBX) fell 1.54% to USD 0.64 as of June 10, 2026 at 04:41 UTC, according to Nexqual real-time market data.
SYBX last closed at USD 0.65; the session ranged USD 0.61–0.64 on volume of 67 shares. Market capitalization is $7.49M, with a 52-week range of USD 0.54–1.96 (PNK). Source: Nexqual, June 10, 2026 at 04:41 UTC.
Key Statistics (as of June 10, 2026 at 04:41 UTC)
| Price | USD 0.64 |
|---|---|
| Change | ▼ 1.54% (down) |
| Previous Close | USD 0.65 |
| Open | USD 0.61 |
| Day Range | USD 0.61 – 0.64 |
| 52-Week Range | USD 0.54 – 1.96 |
| Volume | 67 shares |
| Market Cap | $7.49M |
| Exchange | PNK |
Technical Analysis (SYBX)
Nexqual's technical model rates SYBX "BUY" based on 5 bullish and 3 bearish signals across 123 daily candles, as of June 10, 2026 at 04:41 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 79.2 (overbought) |
| vs SMA50 | Below (USD 0.64) |
| MACD | 0.02 (positive) |
Analyst Ratings (SYBX)
Wall Street analysts rate SYBX "None", per Nexqual as of June 10, 2026 at 04:41 UTC.
| Consensus Rating | None |
|---|
Earnings (SYBX)
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2024-12-31 | USD 0.85 vs est -0.1 ▲ beat |
| 2024-09-30 | USD -0.01 vs est -0.18 ▲ beat |
| 2024-06-30 | USD -0.48 vs est -0.16 ▼ miss |
| 2024-03-31 | USD -0.27 vs est -0.66 ▲ beat |
Source: Nexqual, June 10, 2026 at 04:41 UTC.
Financials & Fundamentals (SYBX)
| Gross Margin | +0.00% |
|---|---|
| Operating Margin | +0.00% |
| Profit Margin | +0.00% |
Source: Nexqual, June 10, 2026 at 04:41 UTC.
Financial Health Score (SYBX)
Nexqual rates Synlogic, Inc.'s overall financial health "Weak" across five dimensions, as of June 10, 2026 at 04:41 UTC.
| Growth | Critical — Revenue -100% YoY (annual), sharp decline |
|---|---|
| Profitability | Weak — Pre-revenue or very early stage |
| Balance Sheet | Mixed — No data |
| Cash Flow | Mixed — No data |
| Efficiency | Mixed — No data |
Ownership (SYBX)
| Insider Ownership | +22.60% |
|---|---|
| Institutional Ownership | +35.28% |
| Shares Outstanding | 11.70M |
| Short % of Float | +0.20% |
Source: Nexqual, June 10, 2026 at 04:41 UTC.
Major Backers & Investors (SYBX)
Notable institutional backers of Synlogic, Inc. include DRW Securities, LLC, according to Nexqual as of June 10, 2026 at 04:41 UTC.
Active Investors
| Investor | Stake |
|---|---|
| DRW Securities, LLC | 0.2% |
Source: Nexqual, June 10, 2026 at 04:41 UTC.
From Synlogic, Inc.'s Latest SEC 10-K Filing (filed 2026-03-12)
Key Strengths & Strategy (as disclosed to the SEC)
- We seek to protect our proprietary technology and processes, in part, by entering into confidentiality agreements with our employees, consultants, collaborators, advisors, independent contractors or other third parties.
- Our success depends in part on our ability to develop, manufacture, market and sell our product candidates and use our proprietary technology without infringing the patent rights of third parties.
- The legal systems of some countries, particularly some developing countries, do not favor the enforcement of patents, trade secrets, and other intellectual property protection, particularly those relating to biopharmaceutical products, which could make it difficult in those jurisdictions for us to stop the infringement or misappropriation of our patents or other intellectual property rights, or the marketing of competing products in violation of our proprietary rights.
- As we outsource more of our information systems to vendors, engage in more electronic transactions with payors and patients, and rely more on cloud-based information systems, the related security risks will increase and we will need to expend additional resources to protect our technology and information systems.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| EVLO | Evelo Biosciences, Inc. | USD 0 | ▲ 200% |
| ASMB | Assembly Biosciences, Inc. | USD 22.72 | ▼ 0.79% |
| CYPH | Cypherpunk Technologies Inc. | USD 0.68 | ▲ 30.17% |
| ELOX | Eloxx Pharmaceuticals, Inc. Common Stock | USD 11.01 | ▲ 77.58% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 04:41 UTC. This page is informational and not investment advice.